Malaysia · Delayed Price · Currency is MYR KLSE:SUNMED Statistics
Total Valuation
KLSE:SUNMED has a market cap or net worth of MYR 24.38 billion. The enterprise value is 24.73 billion.
| Market Cap | 24.38B |
| Enterprise Value | 24.73B |
Important Dates
The last earnings date was Thursday, August 20, 2026.
| Earnings Date | Aug 20, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
KLSE:SUNMED has 11.50 billion shares outstanding. The number of shares has increased by 0.03% in one year.
| Current Share Class | 11.50B |
| Shares Outstanding | 11.50B |
| Shares Change (YoY) | +0.03% |
| Shares Change (QoQ) | +0.08% |
| Owned by Insiders (%) | 0.11% |
| Owned by Institutions (%) | 12.77% |
| Float | 3.09B |
Valuation Ratios
The trailing PE ratio is 86.19 and the forward PE ratio is 74.39. KLSE:SUNMED's PEG ratio is 3.37.
| PE Ratio | 86.19 |
| Forward PE | 74.39 |
| PS Ratio | 9.88 |
| PB Ratio | 7.28 |
| P/TBV Ratio | 7.36 |
| P/FCF Ratio | 544.81 |
| P/OCF Ratio | 59.63 |
| PEG Ratio | 3.37 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 44.86, with an EV/FCF ratio of 552.66.
| EV / Earnings | 87.23 |
| EV / Sales | 10.02 |
| EV / EBITDA | 44.86 |
| EV / EBIT | 73.27 |
| EV / FCF | 552.66 |
Financial Position
The company has a current ratio of 1.59, with a Debt / Equity ratio of 0.49.
| Current Ratio | 1.59 |
| Quick Ratio | 1.49 |
| Debt / Equity | 0.49 |
| Debt / EBITDA | 2.95 |
| Debt / FCF | 36.38 |
| Interest Coverage | 5.30 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 8.43% |
| Return on Capital Employed (ROCE) | 7.45% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, KLSE:SUNMED has paid 24.71 million in taxes.
| Income Tax | 24.71M |
| Effective Tax Rate | 8.02% |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 1.95 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 65.48 |
| Average Volume (20 Days) | 11,471,680 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KLSE:SUNMED had revenue of MYR 2.47 billion and earned 283.56 million in profits. Earnings per share was 0.02.
| Revenue | 2.47B |
| Gross Profit | 1.53B |
| Operating Income | 337.60M |
| Pretax Income | 308.27M |
| Net Income | 283.56M |
| EBITDA | 537.01M |
| EBIT | 337.60M |
| Earnings Per Share (EPS) | 0.02 |
Balance Sheet
The company has 1.28 billion in cash and 1.63 billion in debt, with a net cash position of -351.23 million or -0.03 per share.
| Cash & Cash Equivalents | 1.28B |
| Total Debt | 1.63B |
| Net Cash | -351.23M |
| Net Cash Per Share | -0.03 |
| Equity (Book Value) | 3.35B |
| Book Value Per Share | 0.29 |
| Working Capital | 704.39M |
Cash Flow
In the last 12 months, operating cash flow was 408.88 million and capital expenditures -364.13 million, giving a free cash flow of 44.76 million.
| Operating Cash Flow | 408.88M |
| Capital Expenditures | -364.13M |
| Depreciation & Amortization | 199.42M |
| Net Borrowing | 27.76M |
| Free Cash Flow | 44.76M |
| FCF Per Share | 0.00 |
Margins
Gross margin is 62.04%, with operating and profit margins of 13.68% and 11.49%.
| Gross Margin | 62.04% |
| Operating Margin | 13.68% |
| Pretax Margin | 12.49% |
| Profit Margin | 11.49% |
| EBITDA Margin | 21.76% |
| EBIT Margin | 13.68% |
| FCF Margin | 1.81% |
Dividends & Yields
KLSE:SUNMED does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 252.67% |
| Buyback Yield | -0.03% |
| Shareholder Yield | -0.03% |
| Earnings Yield | 1.16% |
| FCF Yield | 0.18% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for KLSE:SUNMED is 1.96, which is -7.55% lower than the current price. The consensus rating is "Hold".
| Price Target | 1.96 |
| Price Target Difference | -7.55% |
| Analyst Consensus | Hold |
| Analyst Count | 16 |
| Revenue Growth Forecast (3Y) | 17.66% |
| EPS Growth Forecast (3Y) | 24.96% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |